{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:03:16Z","timestamp":1789826596834,"version":"4.0.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.heliyon.2024.e38411","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T21:54:40Z","timestamp":1727301280000},"page":"e38411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Unveiling the potential of medicinal herbs as the source for in vitro screening toward the inhibition of Nrf2"],"prefix":"10.1016","volume":"10","author":[{"given":"Minh Hien","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9585-3222","authenticated-orcid":false,"given":"Nhi Yen Thi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Siao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Thien","family":"Nguyen Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoa Thanh","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hung","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.heliyon.2024.e38411_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The different mechanisms of cancer drug resistance: a brief review","volume":"7","author":"Mansoori","year":"2017","journal-title":"Adv. Pharmaceut. Bull."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e38411_bib2","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e38411_bib3","first-page":"141","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer Drug Resist"},{"issue":"40","key":"10.1016\/j.heliyon.2024.e38411_bib4","doi-asserted-by":"crossref","first-page":"7126","DOI":"10.2174\/13816128113199990493","article-title":"Mechanisms of drug resistance in cancer chemotherapy: coordinated role and regulation of efflux transporters and metabolizing enzymes","volume":"19","author":"Vadlapatla","year":"2013","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.heliyon.2024.e38411_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12935-015-0221-1","article-title":"Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp","volume":"15","author":"Alfarouk","year":"2015","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38411_bib6","first-page":"41","article-title":"Function of insulin-like growth factor 1 receptor in cancer resistance to chemotherapy","volume":"15","author":"Yuan","year":"2018","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e38411_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc2342","article-title":"DNA repair pathways as targets for cancer therapy","volume":"8","author":"Helleday","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.heliyon.2024.e38411_bib8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of Nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e38411_bib9","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1134\/S0006297922120045","article-title":"Does Nrf2 play a role of a master regulator of mammalian aging?","volume":"87","author":"Zinovkin","year":"2022","journal-title":"Biochemistry (Moscow)"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e38411_bib10","doi-asserted-by":"crossref","first-page":"538","DOI":"10.2174\/1568009617666171002144228","article-title":"Oxidative stress and cancer: the role of Nrf2","volume":"18","author":"Sajadimajd","year":"2018","journal-title":"Curr. Cancer Drug Targets"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38411_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","article-title":"NRF2 and the hallmarks of cancer","volume":"34","author":"Chapman","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38411_bib12","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1038\/srep02084","article-title":"Sustained production of ROS triggers compensatory proliferation and is required for regeneration to proceed","volume":"3","author":"Gauron","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e38411_bib13","first-page":"S12","article-title":"Quantitative analysis of proliferation behaviour of ovarian cancer cells with the dynamics of reactive oxygen species production and sequestration","volume":"185","author":"Deeni","year":"2014","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.heliyon.2024.e38411_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jbiotec.2014.09.027","article-title":"Quantitative analysis of NRF2 pathway reveals key elements of the regulatory circuits underlying antioxidant response and proliferation of ovarian cancer cells","volume":"202","author":"Khalil","year":"2015","journal-title":"J. Biotechnol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e38411_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24097839","article-title":"The role of NQO1 in ovarian cancer","volume":"24","author":"Tossetta","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38411_bib16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12935-021-01822-1","article-title":"Targeting Nrf2 may reverse the drug resistance in ovarian cancer","volume":"21","author":"Li","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e38411_bib17","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.freeradbiomed.2011.03.008","article-title":"Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2\/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs","volume":"50","author":"Tang","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"21","key":"10.1016\/j.heliyon.2024.e38411_bib18","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.3390\/molecules26216452","article-title":"Luteolin inhibits breast cancer stemness and enhances chemosensitivity through the Nrf2-mediated pathway","volume":"26","author":"Tsai","year":"2021","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e38411_bib19","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbrc.2011.09.014","article-title":"Enhanced sensitivity of A549 cells to the cytotoxic action of anticancer drugs via suppression of Nrf2 by procyanidins from Cinnamomi Cortex extract","volume":"413","author":"Ohnuma","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2024.e38411_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.abb.2015.09.007","article-title":"Selective antagonization of activated Nrf2 and inhibition of cancer cell proliferation by procyanidins from Cinnamomi Cortex extract","volume":"585","author":"Ohnuma","year":"2015","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.heliyon.2024.e38411_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114134","article-title":"Brusatol: a potential sensitizing agent for cancer therapy from Brucea javanica","volume":"158","author":"He","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e38411_bib22","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1073\/pnas.1014275108","article-title":"Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism","volume":"108","author":"Ren","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.heliyon.2024.e38411_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2360427","article-title":"Brusatol enhances the chemotherapy efficacy of gemcitabine in pancreatic cancer via the Nrf2 signalling pathway","volume":"2018","author":"Xiang","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.heliyon.2024.e38411_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.152680","article-title":"Apoptotic activities of brusatol in human non-small cell lung cancer cells: involvement of ROS-mediated mitochondrial-dependent pathway and inhibition of Nrf2-mediated antioxidant response","volume":"451","author":"Xie","year":"2021","journal-title":"Toxicology"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e38411_bib25","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.7150\/ijbs.82401","article-title":"Natural Nrf2 inhibitors: a review of their potential for cancer treatment","volume":"19","author":"Zhang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"18","key":"10.1016\/j.heliyon.2024.e38411_bib26","doi-asserted-by":"crossref","first-page":"7600","DOI":"10.1021\/jm5007534","article-title":"Novel nitric oxide-releasing derivatives of brusatol as anti-inflammatory agents: design, synthesis, biological evaluation, and nitric oxide release studies","volume":"57","author":"Tang","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e38411_bib27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.freeradbiomed.2014.11.003","article-title":"Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity\u2014implications for therapeutic targeting of Nrf2","volume":"78","author":"Olayanju","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e38411_bib28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.18632\/oncotarget.26625","article-title":"Correction: the Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer","volume":"10","author":"Evans","year":"2019","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e38411_bib29","first-page":"1975","article-title":"Screening for in vitro inhibiting Nrf2 of some Vietnamese medicinal plants","volume":"6","author":"Nguyen","year":"2023","journal-title":"VNUHCM J. Eng. Technol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38411_bib30","first-page":"442","article-title":"Management of cytotoxic chemotherapy-induced hand-foot syndrome","volume":"14","author":"Kwakman","year":"2020","journal-title":"Onco Rev."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e38411_bib31","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/antiox10040544","article-title":"Identification of beilschmiedia tsangii root extract as a liver cancer cell\u2013normal keratinocyte dual-selective NRF2 regulator","volume":"10","author":"Chen","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.heliyon.2024.e38411_bib32","article-title":"alamarBlue assays for cell viability protocol","year":"2019","journal-title":"for Microplates"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e38411_bib33","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.3390\/molecules25071746","article-title":"Chemical constituents with GNMT-promoter-enhancing and nrf2-reduction activities from Taiwan agarwood Excoecaria formosana","volume":"25","author":"Wu","year":"2020","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e38411_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106186","article-title":"Cheburator software for automatically calculating drug inhibitory concentrations from in vitro screening assays","volume":"9","author":"Nevozhay","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e38411_bib35","series-title":"Pharmacopoeia Vietnamica, Fifth Ed, 5th Ed. Ha Noi","year":"2018"},{"key":"10.1016\/j.heliyon.2024.e38411_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112897","article-title":"Piper sarmentosum Roxb.: a review on its botany, traditional uses, phytochemistry, and pharmacological activities","volume":"263","author":"Sun","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38411_bib37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3390\/molecules28010409","article-title":"Assessment of the phytochemical analysis and antimicrobial potentials of zingiber zerumbet","volume":"28","author":"Ramzan","year":"2023","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e38411_bib38","first-page":"4853","article-title":"The antioxidant activity, preliminary phytochemical screening of Zingiber zerumbet and antimicrobial efficacy against selective endodontic bacteria","volume":"11","author":"Assiry","year":"2023","journal-title":"J. Nutr. Sci."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e38411_bib39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0975-3575(10)80120-8","article-title":"Pharmacognostic and phytochemical studies of bark of Oroxylum indicum","volume":"2","author":"Dev","year":"2010","journal-title":"Phcog. J."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38411_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15498-8","article-title":"Antioxidant, cytotoxic and apoptotic activities of the rhizome of Zingiber zerumbet Linn. in Ehrlich ascites carcinoma bearing Swiss albino mice","volume":"12","author":"Ali","year":"2022","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e38411_bib41","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/ptr.7755","article-title":"The critical role of the phytosterols in modulating tumor microenvironment via multiple signaling: a comprehensive molecular approach","volume":"37","author":"Khan","year":"2023","journal-title":"Phytother Res."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e38411_bib42","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1080\/10408398.2020.1835820","article-title":"Phytosterols and phytostanols and the hallmarks of cancer in model organisms: a systematic review and meta-analysis","volume":"62","author":"Cioccoloni","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e38411_bib43","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3390\/cancers14051100","article-title":"Therapeutic potential of certain terpenoids as anticancer agents: a scoping review","volume":"14","author":"Kamran","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38411_bib44","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13046-022-02270-z","article-title":"Brucein D augments the chemosensitivity of gemcitabine in pancreatic cancer via inhibiting the Nrf2 pathway","volume":"41","author":"Zhang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38411_bib45","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/s12935-020-01470-x","article-title":"Stigmasterol sensitizes endometrial cancer cells to chemotherapy by repressing Nrf2 signal pathway","volume":"20","author":"Liao","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.heliyon.2024.e38411_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2012.00130","article-title":"Secondary metabolites from plants inhibiting ABC transporters and reversing resistance of cancer cells and microbes to cytotoxic and antimicrobial agents","volume":"3","author":"Wink","year":"2012","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e38411_bib47","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/molecules27020349","article-title":"Modern approaches in the discovery and development of plant-based natural products and their analogues as potential therapeutic agents","volume":"27","author":"Najmi","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38411_bib48","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3390\/ijms24010595","article-title":"NRF2 in cancer: cross-talk with oncogenic pathways and involvement in gammaherpesvirus-driven carcinogenesis","volume":"24","author":"Cirone","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024144428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024144428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:04:42Z","timestamp":1789823082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024144428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":48,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2405844024144428"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38411","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling the potential of medicinal herbs as the source for in vitro screening toward the inhibition of Nrf2","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38411","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e38411"}}